Clozapine – The Medication People Hope Will Help
Schizophrenia can sometimes respond well to treatment. Someone might try a medication, find that voices, paranoia, disorganized thinking, or severe agitation begin to ease, and that they can gradually reclaim the pieces of their usual routine. But for others, symptoms persist despite what seems like treatment that should be optimal. When two attempts to get other medicines to work for the psychosis, two conscientiously-tried trials, have not worked well enough, clozapine usually becomes the next medication to consider.
Welcome to the Neuroscience Research and Development Consultancy website. If you would like more information about any of the topics we cover on our site, or if you have a question. a comment, or a critique, please send it to us at: Comment@NeuroSciRandD.com
Clozapine Really Is Special
Clozapine became available in Europe in 1972 and was approved by the US FDA in 1989. It’s widely considered the most effective medicine for schizophrenia, especially treatment-resistant schizophrenia. “Treatment-resistant” means that two other medications have been tried and have not worked well enough. For many people, clozapine is the medication that finally brings meaningful relief after other medicines have failed. It can reduce persistent psychosis and, in some individuals, might also help lower the risk of suicide and severe aggression.
While Clozapine is a Powerful Medicine the Side Effects Can Be Awful
Clozapine is not an easy medication to take. That’s why, even though it’s considered the most effective medicine for schizophrenia, it’s usually not the first one tried. One might need regular blood tests since it can rarely sharply lower infection-fighting white blood cells. It could also cause constipation so bad that it can be fatal, excess salivation, sleepiness, weight gain, dizziness, metabolic problems, and seizures. Awful stuff. Early in the course of using clozapine it could prompt inflammation that could affect one’s heart. Such bad side effects are scary, but after someone has tried several others that didn’t work, risking such possible side effects might be worth it if clozapine helps a lot.

When the One That’s Supposed To Work, Clozapine, Falls Short
But even apart from the side effects, clozapine does not work well enough for everyone. Some patients get only partial relief. They might feel less distressed or be less likely to need hospitalization, but maybe they’re still hearing voices or troubled by false beliefs. Other patients cannot continue taking clozapine because they do get the side effects and can’t tolerate them. This presents quite a dilemma. There isn’t study-supported information on what to do next.
There’s a Name for the Problem: Clozapine-Resistant Schizophrenia
One could use the term clozapine-resistant schizophrenia when problem symptoms continue despite a giving it a good try to use clozapine. The term is just a description of the clinical situation that clozapine has been given a fair chance, yet the patient is still unwell and unhappy about it. Don’t take the term as a crystal ball predicting a sad future. Clozapine not working signals doctor and patient alike to go over the treatment plan and come up with a next step. It’s not a reason to stop searching for ways to improve life.

First, Make Sure the Clozapine Trial Was Fair
Before the doctor and patient decide that clozapine has failed to work as planned they need to ask themselves a few practical questions. Mr. Patient, have you taken it regularly? Doctor, did you increase the dose cautiously and did you take it high enough? Did you take the top therapeutic dose long enough that it should have worked? Are smoking, other medicines, illness, or missed doses changing the amount of clozapine in the bloodstream? These details outline the difference between a true lack of good effect as opposed to a treatment that was never fully tested.
Slow and Careful Clozapine Dose Increases
Clozapine is ordinarily started at a low dose and increased gradually. Such a schedule protects patients from potentially serious early side effects, including excessive sedation, dangerously low blood pressure, seizures, and heart muscle inflammation. “Start low and go slow” is a good clozapine protocol. Slow titration does, of course, mean that a person might spend too long a time below a helpful dose, so physicians do need to eventually try pushing the dose higher.
Why Clozapine Blood Levels Matter
The clozapine dose that you swallow is measured in milligrams, but how much you take doesn’t tell the whole story. Two people taking the same number of pills might well have very different blood concentrations of the medication, and blood concentration is what treats the psychosis. Smoking tobacco, for example, can speed clozapine’s breakdown, so one needs higher dose. Caffeine, on the other hand, can boost the level in the blood, so a lower dose might work. Other medicines, infections, and genetic differences can affect blood levels. A clozapine blood test can tell whether the level was high enough to assess its benefit fairly.
Clozapine’s Three-Month Benchmark
There’s a large group of schizophrenia experts working together around the world to solve barriers to successful psychosis treatment. The group is called the Treatment Response and Resistance in Psychosis Working Group, acronym TRRIP. They recommend to physicians to allow at least three months of treatment after an adequate clozapine blood level has been reached before concluding that it hasn’t worked. They provide specific levels that are considered “adequate’.
A Higher Clozapine Blood Level Is Not Automatically Better
If the clozapine blood level is below their adequate needed level, and if side effects permit, the first recommendation from this group is to consider a careful gradual dose increase. This is not a contest to reach the highest possible number. Higher clozapine levels might increase the likelihood of side effects, including seizures, and the benefits beyond a certain point are uncertain. The goal is just an individually appropriate and tolerable exposure for that specific patient, guided by symptoms, side effects, blood levels, health monitoring, and shared doctor-patient decision-making.
The Treatment Response and Resistance in Psychosis Working Group – A Survey
The recommendations from the group are a consensus opinion, not a magic formula. The Wagner paper didn’t present new clinical data supporting one specific “next step”. Instead, the authors surveyed this group of experienced international specialists about what they would recommend in a situation where solid guiding research evidence is limited. The participating experts each have extensive clinical experience and they come from multiple countries. Their answers are useful, remarkably so, but they should be understood as an informed consensus of opinion, not as a guarantee that the same approach will help every individual.
Match the Treatment Plan to the Patient’s Main Problem
One important message from the group is that “not enough response” can mean very different things. Persistent hallucinations or delusions are not the same as severe social withdrawal, lack of motivation, suicidal thinking, aggression, depression, medication side effects, or trouble functioning at work or home. A good treatment plan begins with identifying the patient’s most urgent remaining problem. That matters because the best-supported next step will probably differ depending on which symptoms are causing the greatest upset for the patient.
Adding a Second Psychosis Medicine to Clozapine
For continuing positive symptoms like distressing voices, paranoia, or strongly held false beliefs the Psychosis Working Group most often endorsed adding another antipsychotic while continuing clozapine. The two drugs to add that had the most votes were oral aripiprazole and or amisulpride. Amisulpride is not available in the US and some other countries. The recommendation was not to lower clozapine but to add the second medication, aripiprazole, and not change the clozapine dose unless one has to for safety.

Why A Combination with Clozapine Is Considered
The logic behind combination treatment is that medicines that treat psychosis don’t all act in exactly the same way, that is, they have differing mechanisms of action. Clozapine by itself has an unusual pharmacologic profile, a “rich pharmacology”, as they say. A second medicine might add a useful new effect for a person whose psychosis has improved on clozapine, but only partly. That’s the benefit, but combining medications also increases complexity. There might be more side effects, more interactions, more pills, and more uncertainty about which one is helping or harming. Adding the second drug needs to be a deliberate, thought-through, monitored trial, not a hurried “stick it on” automatic layering-on of drugs.
There Was an Add-On to Clozapine That the Group Didn’t Endorse
The Treatment Response and Resistance in Psychosis Working Group did not reach consensus for routinely adding medicines for depression to clozapine to treat persistent positive symptoms. The group also did not endorse a long list of speculative add-ons sometimes promoted online or in off-the-cuff discussions. It’s not that every option that they didn’t endorse is necessarily useless, it just means the group did not find sufficient agreement or persuasive evidence to recommend that specific treatment for this specific clozapine situation.

ECT Is a Modern Medical Treatment
When persistent positive symptoms remain severe, the Psychosis Working Group also supported considering electroconvulsive therapy, or ECT, as an addition to ongoing clozapine. Sadly and unfortunately, ECT has a public image shaped by old movies and frightening historical accounts, but modern ECT is a carefully-controlled medical procedure performed under general anesthesia with full muscle relaxation. It intentionally produces a brief seizure while the patient is closely monitored by an experienced medical team. Today’s ECT is so gentle that it’s often recommended for refractory depression in the elderly and with pregnant women.
ECT and Persistent Psychosis
For clozapine-resistant positive symptoms (e.g., hallucinations, delusions, paranoia), the Psychosis Working Group supported a course of about 12 ECT treatments, commonly delivered three times each week for four weeks. If a person improves, continuation or maintenance ECT might be considered if needed to help preserve the gain. It’s well understood that ECT is not a trivial intervention, and that it can cause temporary confusion or memory problems, among other risks. Yet for someone with severe, ongoing psychosis despite clozapine, it can be a life-saver, so a serious and reasonable option to discuss.
Clozapine Plus Therapy Remains a Great Plan
Medication is not the entire treatment plan for schizophrenia whether symptoms are mild or intense. One cannot just toss a pill at someone and magically they’re well. For persistent positive symptoms the Psychosis Working Group recommended cognitive-behavioral therapy for psychosis (CBTp), as an additional approach. Apart from the Group’s recommendations, it might have been a good plan to start cognitive-behavioral therapy for psychosis when that first medication was tried, way before clozapine. Cognitive-behavioral therapy for psychosis doesn’t require a patient to try to dismiss a perception that feels real. Instead, it can help them examine interpretations, notice triggers, reduce distress, develop coping strategies, and regain practical control over daily life.

Sixteen or More Sessions of Cognitive-behavioral Therapy for Psychosis
One does have to give psychotherapy enough time to be work. The Treatment Response and Resistance in Psychosis Working Group were of the opinion that one needed at least 16 Cognitive-behavioral Therapy for Psychosis sessions to expect a beneficial reduction in persistent positive symptoms. We would emphasize the “at least”, as AT LEAST. There’s the danger than a physician or patient will have 16 sessions and decide that’s “one and done” for therapy. Nope! If there’s a partial benefit one should keep going. I suppose if there’s no benefit, zero, zilch, zip benefit, after 16 sessions, then one might stop.
Plain Vanilla Cognitive-behavioral Therapy for Negative Symptoms
Then there are the negative symptoms, low motivation, little emotional expression, not talking much, avoiding social interaction, nothing is fun. The Working Group recommended regular Cognitive-behavioral Therapy (that is, not the version designed for psychosis) and help with psychosocial interventions. Negative symptoms are really badly disabling even without the positive symptoms like hallucinations and delusions. Treating negative symptoms needs approaches that focus on routines, goals, skills, relationships, and meaningful activity.
Psychosocial Approaches the Bedrock Foundation for Success
“Psychosocial” interventions are brain changing and life changing. “Psychosocial” is not just touchy, feely, get-a-hug stuff. It can rewire your brain circuits. Things like family education and support, social-skills role-playing, help with employment or education, confirming housing and daily structure, substance-abuse treatment if needed, dietary education, and physical exercises and activities. These fold into a comprehensive medical care program. Psychosocial interventions are not done instead of needed medical care. These therapeutic interventions treat areas of health that a drug, by itself, cannot help. Patients with schizophrenia and psychosis often suffer with isolation, disrupted routines, unemployment, strained relationships, and the practical consequences of years spent ill.
Just When You Thought Everything Was Going in the Right Direction – Suicide
This is where psychosis and schizophrenia become a fatal disease. Like sudden cardiac death, suicide can appear. So, if suicidal thoughts or worse, behaviors toward suicide, become the central concern, the Psychosis Working Group went a different direction, not just upping clozapine or adding another drug. They emphasized the above mentioned psychosocial approaches and regular Cognitive-behavioral Therapy as additions to clozapine. Indications of immediate danger require urgent, supportive, individual medical assessment. Family members, friends, even acquaintances need to listen carefully and take statements seriously about wanting to hurt oneself or wanting to die. Drag the person to emergency help when safety is in question rather than waiting to see whether the feeling passes.
Psychosis Plus Aggression – A Dangerous Mix
The old psychoanalysts used to say that suicide is anger turned inward and aggression is anger turned outward. That’s pretty abstract and theoretical. Treating aggression needs action, not theorizing. Move and move quickly. When aggression has emerged as the key problem, the Psychosis Working Group said to consider an add-on mood stabilizer or adding another antipsychotic alongside clozapine, while also employing psychosocial care. We would reverse that order. First, aggressively jump in to contain the aggression and urgently look for the cause or trigger. Has it appeared because of untreated psychosis, or fear, or trauma, or substance use, or delirium, or medication side effects, or conflict, or an unsafe environment? It’s not just a character flaw and should never be assumed to be a simple character flaw and not actively treated. A careful but quick assessment of what is driving the behavior is essential for choosing treatment approaches that protect everyone’s safety.
These Experts Didn’t Know How To Use Repetitive Transcranial Magnetic Stimulation
Our esteemed Treatment Response and Resistance in Psychosis Working Group drew a blank on this one. Or, to be kind, they didn’t agree on a consensus recommendation for clozapine-resistant schizophrenia. We’re talking about Repetitive Transcranial Magnetic Stimulation (rTMS). It seems like a near-miraculous treatment but for now it remains an area of research rather than a clear next step. Repetitive Transcranial Magnetic Stimulation uses magnetic pulses from a device held near the head, outside the scalp, to influence specific targeted brain circuits. It doesn’t need any type of anesthesia and it doesn’t need to cause a seizure. The medical research community has studied it in recent years for several psychiatric conditions, including some symptoms of schizophrenia.
If Clozapine Seems Not To Be Working, Don’t Quickly Stop It
It’s a “knee jerk” reaction. Gee, clozapine doesn’t seem to help, let’s just stop it. This is simplistic (or we might pejoratively say stupid) thinking. Just because clozapine doesn’t eliminate all the symptoms of treatment resistant schizophrenia is not, by itself, a reason to abruptly abandon it. The Psychosis Working Group really advised against stopping it because positive or negative symptoms are still present. Even partial benefit can be important. If the patient has fewer crises, less terror from voices, better sleep, less aggression, or more ability to participate in treatment, that’s enough. Stopping clozapine can lead to relapse, so any decision to reduce or discontinue it must be carefully planned and the taper monitored closely.
Stop Clozapine If…
There are times when one has to stop clozapine even if it seems to be working. Stop it if it’s causing side effect that the patient can’t tolerate. If there’s not a dose that seems to provide some benefit with the side effects still moderate, stop it. Stop it if it causes a bad reaction, like a serious allergic reaction. (Anaphylaxis can be fatal.) Stop it if it causes some other safety concern. These decisions are made for each specific patient by the patient and their physician. Stop it immediately if an urgent medical situation demands it. Otherwise, clozapine needs to be tapered gradually since stopping it too quickly can allow the rapid return of the symptoms it is meant to treat. The doctor can plan a gradual taper.
Precision Medicine Means Individualized Care
No distant expert or group or journal article can dictate the best next step for any one specific patient. As the doctor and patient discuss the ongoing symptoms, past treatment responses, medical conditions, other necessary medications, likes and dislikes, and access to therapy and to ECT, a next step forward will emerge. And, the decision will evolve and maybe change at each visit.

Schizophrenia Not Helped by Clozapine Presents a Real Challenge
When one discovers that their psychosis is not treated well enough even by clozapine it can be disheartening. It’s time for a doctor-patient “sit down and discuss” meeting, an honest and open back-and-forth on what do we do next. It leaves behind the comfort of solid, study-proven medical science and moves forward into medical expertise and patient preferences. The groundwork must be laid for a carefully planned trial to try to optimize clozapine, think through targeted augmentation, agree on a yes or no on ECT, get the right psychotherapy with the right psychotherapist in place, find and shore up life’s practical supports, and track progress or lack thereof closely. The goals are relief, stability, connection, and a more livable life.
Reference
Wagner E, Kane JM, Correll CU, Howes O, Siskind D, Honer WG, Lee J, Falkai P, Schneider-Axmann T, Hasan A; TRRIP Working Group. Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia: Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group. Schizophrenia Bulletin. 2020;46(6):1459–1470.










When I sit across from someone hearing the word “schizophrenia” for the first time, I’m not thinking about receptors and scan results. I’m thinking about a life that just swerved off the road, and about how we can coax it back, inch by inch, without losing the person along the way.
For families who have watched someone they love struggle through multiple medications, hospitalizations, and side effects, this pipeline is not abstract; it is the possibility that the next drug we try will work differently enough to finally help where others have failed.
Here, structured therapies matter: social skills training, cognitive remediation, supported employment and education, and family interventions that teach everyone how to navigate stress and relapse warning signs. Occupational therapy and day programs can help rebuild routines and confidence. Even simple, steady physical exercise, for example, walking most days of the week, has evidence for improving mood, cognition, and overall functioning.

